US Futures gaining ground - Watch AMZN, AAPL, MRNA, SLB, BIIB, HAS

,

The S&P 500 Futures are rebounding after they sank further on Friday

Stocks (1)

The S&P 500 Futures are rebounding after they sank further on Friday. Escalating tensions between the U.S. and China started to drag the feet of market bulls.

Later today, the U.S. Commerce Department will report Durable Goods Orders for June (preliminary readings). July Dallas Fed Manufacturing Index is also expected.

European indices are posting a rebound. Germany's IFO Business Climate Index at 90.5 (vs 89.3 expected) and Expectations Index at 97.0 (vs 93.4 expected) for July were released. The European Central Bank has reported M3 Money Supply growth in June at +9.2% (vs +9.3% on year expected).

Asian indices closed mixed as Beijing ordered the U.S. consulate in Chengdu city to close in retaliation against the U.S. which shut the Chinese consulate in Houston.

WTI Crude Oil futures are under pressure. The number of U.S. rigs dropped to 251 for the week ended 24 from 253, while the amount of rigs in Canada increased to 42 from 32, according to Baker Hughes.

Gold climbed to an all-time high while the US dollar index fell to a two-year low on US-China tensions and COVID-19 fears.

Gold rose 39.93 dollars (+2.1%) to 1941.95 dollars.

The dollar index fell 0.63pt to 93.805.


U.S. Equity Snapshot


Amazon.com's (AMZN), the e-commerce giant, price target was raised to 3,600 dollars from 2,800 dollars at Telsey, and to 3,600 dollars from 3,000 dollars at Wells Fargo. Separately, according to Reuters, the company plans to add 1,000 jobs in Ireland over two years, bringing total workforce in the country to 5,000.



Source: TradingView, Gain Capital

Apple's (AAPL), the tech giant, price target was raised to 425 dollars from 365 dollars at JPMorgan.

Moderna (MRNA), the biotech, "announced that the Phase 3 study of its mRNA vaccine candidate (mRNA-1273) against COVID-19 has begun." The company expects to enroll 30,000 participants in the US.

Schlumberger (SLB), the world's largest supplier of oil and gas products and services, was upgraded to "buy" from "neutral" at Citigroup. Target price was raised to 26 dollars from 20 dollars.

Biogen (BIIB), a pharmaceutical company, was upgraded to "overweight" from "underweight" at Morgan Stanley.

Hasbro (HAS), the toy maker, is losing ground before hours after posting quarterly results that missed estimates.

More from Equities

Disclaimer

This report is intended for general circulation only. It should not be construed as a recommendation, or an offer (or solicitation of an offer) to buy or sell any financial products. The information provided does not take into account your specific investment objectives, financial situation or particular needs. Before you act on any recommendation that may be contained in this report, independent advice ought to be sought from a financial adviser regarding the suitability of the investment product, taking into account your specific investment objectives, financial situation or particular needs.

GAIN Capital Singapore Pte. Ltd., may distribute reports produced by its respective foreign entities or affiliates within the GAIN Capital group of companies or third parties pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed to a person in Singapore who is not an accredited investor, expert investor or an institutional investor (as defined in the Securities Futures Act), GAIN Capital Singapore Pte. Ltd. accepts legal responsibility to such persons for the contents of the report only to the extent required by law. Singapore recipients should contact GAIN Capital Singapore Pte. Ltd. at 6826 9988 for matters arising from, or in connection with the report.

In the case of all other recipients of this report, to the extent permitted by applicable laws and regulations neither GAIN Capital Singapore Pte. Ltd. nor its associated companies will be responsible or liable for any loss or damage incurred arising out of, or in connection with, any use of the information contained in this report and all such liability is hereby expressly disclaimed. No representation or warranty is made, express or implied, that the content of this report is complete or accurate.

GAIN Capital Singapore Pte. Ltd. is not under any obligation to update this report.

Trading CFDs and FX on margin carries a high level of risk that may not be suitable for some investors. Consider your investment objectives, level of experience, financial resources, risk appetite and other relevant circumstances carefully. The possibility exists that you could lose some or all of your investments, including your initial deposits. If in doubt, please seek independent expert advice. Visit cityindex.com.sg for the complete Risk Disclosure Statement.

Important Notice:

Cryptocurrencies are not legal tender currency and trading of derivatives on Cryptocurrencies are currently not covered under any regulatory regime in Singapore. Consequently, investors should be aware they do not have protection under the Securities and Futures Act (Cap. 289). Please ensure that you are fully aware of the risks.